top of page
David A. Silbersweig, M.D.


Dr. David Silbersweig graduated from Dartmouth College with high honors in philosophy. He studied medicine at Cornell University Medical College. He is a neurologist and psychiatrist, having trained in both psychiatry and neurology at The New York Presbyterian Hospital-Weill Cornell Medical Center. His research training was in the emerging field of functional brain imaging research at The Medical Research Council Cyclotron Unit, Hammersmith Hospital, London. Dr. Silbersweig the returned to Cornell to found and direct the Functional Neuroimaging Laboratory with Dr. Emily Stern. Dr. Silbersweig was also the founding Director of the Division of Neuropsychiatry, as well as the founding Director of the Neurology-Psychiatry Combined Residency Program. At Cornell, Dr. Silbersweig was the Tobin-Cooper Professor of Psychiatry, Professor of Neurology and Neurosciences, and was Vice Chairman, for Research, in the Department of Psychiatry. Dr. Silbersweig is now the Chairman of the Department of Psychiatry at the Brigham and Women’s/Faulkner Hospitals, and Chairman of the Brigham and Women’s Hospital Institute for the Neurosciences. He is Stanley Cobb Professor of Psychiatry at Harvard Medical School. 

Aaron T. Beck, M.D.


Aaron T. Beck, M.D., is globally recognized as the father of cognitive therapy (CT) and one of the world's leading researchers in psychopathology.  He has been credited with shaping the face of American psychiatry, and The American Psychologist has called him "one of the five most influential psychotherapists of all time."


Dr. Beck graduated from Brown University in 1942 and Yale Medical School in 1946. Originally trained as a psychoanalyst, his explorations into psychoanalytic concepts of depression while working as a psychiatrist at the University of Pennsylvania led to his development of CT, which has since been demonstrated to be effective for a wide variety of disorders. Today, he is University Professor Emeritus of Psychiatry at Penn, where he remains active in research.

John T. Walkup, M.D. 


John T. Walkup, MD is Professor of Psychiatry, DeWitt Wallace Senior Scholar, the Vice Chair of Psychiatry, and Director of the Division of Child and Adolescent Psychiatry, Weill Cornell Medical College and NewYork-Presbyterian Hospital. Prior to joining the faculty at Weill Cornell, Dr. Walkup spent 20 years at Johns Hopkins School of Medicine serving as Professor of Psychiatry and Behavioral Sciences and Deputy Director in the Division of Child and Adolescent Psychiatry. He had a joint appointment in the Center for American Indian Health at the Johns Hopkins Bloomberg School of Public Health where he was Director of Behavioral Research. Dr. Walkup has three main academic areas of interest. His work with Tourette syndrome, uniquely spans psychiatry, child psychiatry and neurology; his expertise in interventions research focuses on the development and evaluation of psychopharmacological and psychosocial treatments for the major psychiatric disorders of childhood including anxiety, depression, bipolar disorder, Tourette syndrome and suicidal behavior; and lastly, he has been involved in developing and evaluating interventions to reduce the large mental health disparities facing Native American youth, specifically drug use and suicide prevention.

Kim T. Mueser, Ph.D. 


Kim T. Mueser, Ph.D. is a clinical psychologist and Executive Director of the Center for Psychiatric Rehabilitation at Boston University. Dr. Mueser’s clinical and research interests include family psychoeducation, the treatment of co-occurring psychiatric and substance use disorders, psychiatric rehabilitation for serious mental illnesses, and the treatment of posttraumatic stress disorder. His research has been supported by the National Institute of Mental Health, the National Institute on Drug Abuse, the Substance Abuse and Mental Health Administration, and the National Alliance for Research on Schizophrenia and Depression. He is the co-author of over 10 books and treatment manuals, and has published extensively, including numerous peer reviewed journal articles and book chapters. Dr. Mueser has also given numerous lectures and workshops on psychiatric rehabilitation, both nationally and internationally.

Valerie Reyna, Ph.D.


Valerie Reyna is Professor of Human Development and Psychology at Cornell University, Co-Director of the Cornell University Magnetic Resonance Imaging Facility, and a Co-director of the Center for Behavioral Economics and Decision Research. Dr. Reyna holds a Ph.D. in experimental psychology from Rockefeller University. Her research encompasses human judgment and decision making, numeracy and quantitative reasoning, risk and uncertainty, medical decision making, social judgment, and false memory. She is a developer of fuzzy-trace theory, a model of the relation between mental representations and decision making that has been widely applied in law, medicine, and public health. Her recent work has focused on aging, neurocognitive impairment, and genetic risk factors (e.g., in Alzheimer’s disease); rationality and risky decision making, particularly risk taking in adolescence; and neuroimaging models of framing and decision making. She has also extended fuzzy-trace theory to risk perception, numeracy, and dual processes in medical decision making by both physicians and patients. Dr. Reyna also teaches an undergraduate and a graduate seminar on Risk and Rational Decision Making. 

Kenneth W. Griffin, Ph.D.


Dr. Kenneth Griffin is a Professor of Public Health in the Division of Prevention and Health Behavior in the Department of Public Health at Weill Medical College of Cornell University. His research interests focus on the etiology and prevention of substance use and HIV risk behaviors among adolescents and young adults. Dr. Griffin's etiology work has focused on how social, cognitive, affective, and behavioral self-regulation strategies act as protective factors for risky behavior among youth. His prevention work has focused on the design, implementation, and evaluation of preventive intervention programs for youth, mediating mechanisms and generalizability of intervention effects to related risk behaviors, and issues related to disseminating evidence-based prevention programs internationally. His current research is supported by the National Institute on Drug Abuse and the National Institute on Alcoholism and Alcohol Abuse. Dr. Griffin has worked with universities, community-based organizations, and health promotion organizations both domestically and internationally in developing, implementing, and evaluating programs to prevent health and behavior problems among young people. 

bottom of page